Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02514265 · ClinicalTrials.gov registry record
Trans-MAPP Symptom Patterns Study (SPS)
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 640
- Enrollment target
NCT02514265: Completed study, sponsored by University of Pennsylvania.
NCT02514265 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 640 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02514265 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 640 participants
- Enrollment target
Study Summary
This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS), enriched with pre-defined subgroups, with longer follow-up, in order to further investigate clinical and biologic factors associated with worsening and/or improvement of reported urinary and non-urinary symptoms.
Primary Outcome
The Pain severity Score is constructed from the GUPI pain subscale score (0-23) and ICSI Q4: Bladder pain score (0-5), summed to create a primary outcome for UCPPS pain, ranging from 0 to 28.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2020-06 |
What the finished NCT02514265 record still lists
NCT02514265 is an observational study that tracks outcomes without assigning an intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02514265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02514265 about?
NCT02514265 is a clinical study titled "Trans-MAPP Symptom Patterns Study (SPS)". This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS), enriched with pre-defined subgroups, with longer follow-up, in order to further investigate clinical and biol...
What is the current status of trial NCT02514265?
This trial is currently completed. The enrollment target is 640 participants. The study started on 2015-07-01. Estimated completion is 2020-06.
Who is sponsoring clinical trial NCT02514265?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI